ATE79632T1 - Tumorverbundenes antigen. - Google Patents

Tumorverbundenes antigen.

Info

Publication number
ATE79632T1
ATE79632T1 AT86303042T AT86303042T ATE79632T1 AT E79632 T1 ATE79632 T1 AT E79632T1 AT 86303042 T AT86303042 T AT 86303042T AT 86303042 T AT86303042 T AT 86303042T AT E79632 T1 ATE79632 T1 AT E79632T1
Authority
AT
Austria
Prior art keywords
antigen
associated antigen
tumor
cck061
glycoprotein
Prior art date
Application number
AT86303042T
Other languages
English (en)
Inventor
Lana Grauer
Julia Leung
Joy Koda
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Application granted granted Critical
Publication of ATE79632T1 publication Critical patent/ATE79632T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1063—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT86303042T 1985-04-22 1986-04-22 Tumorverbundenes antigen. ATE79632T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72620285A 1985-04-22 1985-04-22
EP86303042A EP0200464B1 (de) 1985-04-22 1986-04-22 Tumorverbundenes Antigen

Publications (1)

Publication Number Publication Date
ATE79632T1 true ATE79632T1 (de) 1992-09-15

Family

ID=24917624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86303042T ATE79632T1 (de) 1985-04-22 1986-04-22 Tumorverbundenes antigen.

Country Status (9)

Country Link
EP (1) EP0200464B1 (de)
JP (1) JPS61289897A (de)
AT (1) ATE79632T1 (de)
AU (2) AU599589B2 (de)
DE (1) DE3686438T2 (de)
DK (1) DK185086A (de)
ES (2) ES8800604A1 (de)
FI (1) FI87141C (de)
NO (1) NO170810C (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
JPS63157995A (ja) * 1986-12-18 1988-06-30 Kyowa Hakko Kogyo Co Ltd 抗ヒト大腸癌単クロ−ン性抗体ａｃｃ−５７４
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
JP2688824B2 (ja) * 1987-05-29 1997-12-10 郁男 山科 単クローン抗体ｎｋｙ１３
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
HU213222B (en) * 1987-07-02 1997-03-28 Akzo Nv Method for producing of tumor antigen recognized by monoclonal antibody, antibody directed against antigen anp antibody specific to antiidiotypic antigen
EP0397419A3 (de) * 1989-05-10 1991-04-03 Hybritech Incorporated Tumorassoziiertes Antigen, Antikörper sowie Zusammensetzungen und Verwendung hierfür
EP0491867B1 (de) * 1989-09-15 1996-11-27 Genetic Systems Corporation HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
AU2001252945A1 (en) * 2000-03-24 2001-10-08 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer
US20120021444A1 (en) * 2008-12-18 2012-01-26 Eidia Co., Ltd. Method for diagnosis of cystic fibrosis using kl-6 levels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
NO861491L (no) * 1985-04-22 1986-10-23 Hybritech Inc Antistoff, fremgangsmaate for dets fremstilling og anvendelse for deteksjon og diagnose av canser.

Also Published As

Publication number Publication date
JPS61289897A (ja) 1986-12-19
EP0200464A3 (en) 1988-05-04
NO861577L (no) 1986-10-23
ES554209A0 (es) 1987-11-16
FI861692A0 (fi) 1986-04-22
ES557680A0 (es) 1989-05-16
NO170810C (no) 1992-12-09
DK185086A (da) 1986-10-23
FI87141C (fi) 1992-12-10
FI861692A (fi) 1986-10-23
AU627084B2 (en) 1992-08-13
AU6556990A (en) 1991-01-17
DK185086D0 (da) 1986-04-22
DE3686438T2 (de) 1993-01-21
EP0200464B1 (de) 1992-08-19
DE3686438D1 (de) 1992-09-24
AU5646986A (en) 1987-10-29
NO170810B (no) 1992-08-31
AU599589B2 (en) 1990-07-26
EP0200464A2 (de) 1986-11-05
ES8800604A1 (es) 1987-11-16
ES8900247A1 (es) 1989-05-16
FI87141B (fi) 1992-08-31

Similar Documents

Publication Publication Date Title
ATE117370T1 (de) Chimärer antikörper mit spezifität für menschliches tumor-antigen.
ATE56046T1 (de) Monoklonale antikoerper gegen humane brustkarzinomzellen und ihre verwendung in der diagnose und therapie.
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
ATE79632T1 (de) Tumorverbundenes antigen.
ES8800603A1 (es) Un metodo para producir anticuerpos monoclonales
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
ATE86261T1 (de) Tumorassoziiertes antigen.
ATE92081T1 (de) Tumorassoziiertes antigen.
EP0397419A3 (de) Tumorassoziiertes Antigen, Antikörper sowie Zusammensetzungen und Verwendung hierfür
DE69229573T2 (de) Monoklonaler Antikörper, Polypeptide und deren Herstellung
EP0332421A3 (en) Monoclonal antibodies recognizing human psti, hybridomas producing the same, and their preparation and use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee